Table 4.
S-25(OH)D concentration (nmol/L) among hip fracture patients in the present study (n=2451) and in the previous study (n = 223) [9] according to the place of residence
| S-25(OH)D | Present study (2015–2016) | Previous study (2003–2004) [9]2 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actual home | Residential home | Residential home (24-h staff) | Institution | Total | Actual home | Residential home | Institution | Total | ||||||||||
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
| < 25 | 13 | 7.5 | 1 | 4.2 | 1 | 2.7 | 0 | 0 | 15 | 6.1 | 33 | 22.6 | 8 | 22.2 | 10 | 24.4 | 51 | 22.8 |
| 25–49 | 27 | 15.5 | 4 | 16.7 | 7 | 18.9 | 2 | 22.2 | 40 | 16.4 | 79 | 54.1 | 20 | 55.6 | 23 | 56.1 | 122 | 54.7 |
| 50–74 | 55 | 31.6 | 7 | 29.2 | 12 | 32.4 | 1 | 11.1 | 75 | 30.7 | 29 | 19.9 | 6 | 16.6 | 8 | 19.5 | 43 | 19.3 |
| 75–120 | 66 | 37.9 | 11 | 45.8 | 15 | 40.5 | 5 | 55.5 | 97 | 39.8 | 5 | 3.4 | 2 | 5.6 | 0 | 0 | 7 | 3.1 |
| > 120 | 13 | 7.5 | 1 | 4.2 | 2 | 5.4 | 1 | 11.1 | 17 | 7.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 174 | 100 | 24 | 100 | 37 | 100 | 9 | 100 | 244 | 100 | 146 | 100 | 36 | 100 | 41 | 100 | 223 | 100 |
1One sample missing; present study: Kruskal-Wallis H = 1.039, d.f. = 3, n.s
2Data re-analyzed in accordance with the prevailing S-25(OH)D classification; previous study:Kruskal-Wallis H = 0.465, d.f. = 2, n.s